By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Actinium Pharmaceuticals, Inc. 

501 Fifth Avenue

New York City  New York  10017  U.S.A.
Phone: 646-459-4201 Fax: n/a


Company News
Actinium Pharmaceuticals, Inc. (ATNM.OB) Announces Pricing Of Public Offering Of Common Stock And Warrants To Purchase Common Stock 2/6/2015 10:52:56 AM
MD Anderson Cancer Center Department Chair Richard E. Champlin, M.D. Joins Actinium Pharmaceuticals, Inc. (ATNM.OB)’s Iomab™-B Scientific Advisory Board 9/10/2014 10:10:54 AM
Actinium Pharmaceuticals, Inc. (ATNM.OB) Files Orphan Drug Application For Use Of Actimab-A In The Treatment Of Newly Diagnosed Acute Myeloid Leukemia In Elderly Patients 9/3/2014 12:24:53 PM
Actinium Pharmaceuticals, Inc. (ATNM.OB) To Present At Rodman & Renshaw Annual Global Investment Conference On September 10th 8/28/2014 12:36:42 PM
Actinium Pharmaceuticals, Inc. (ATNM.OB) To Present At The Canaccord Genuity 34th Annual Growth Conference On August 13th 8/5/2014 9:49:29 AM
Actinium Pharmaceuticals, Inc. (ATNM.OB) Provides Mid-Year Update Directed At Existing And Future Shareholders 8/4/2014 11:42:30 AM
Baylor Sammons Cancer Center Joins As Clinical Trial Site For Actinium Pharmaceuticals, Inc. (ATNM.OB)’s Actimab-A Clinical Trial 7/30/2014 9:56:29 AM
Actinium Pharmaceuticals, Inc. (ATNM.OB) Announces Launch Of Additional Antibody Actinium-225 Labeling Program 7/16/2014 9:36:35 AM
Actinium Pharmaceuticals, Inc. (ATNM.OB) Announces Exercise Of Greenshoe Option 7/11/2014 9:14:13 AM
Baylor Oncology Medical Director Joins Actinium Pharmaceuticals, Inc. (ATNM.OB)’s Iomab-B Scientific Advisory Board 7/8/2014 11:10:02 AM